Arrowhead Pharmaceuticals to host webinar on interim ARO-MAPT clinical data

The webinar is scheduled for Wednesday, October 14, 2026 at 11:30 AM PDT and will focus on investigational therapy ARO-MAPT and Arrowhead's CNS pipeline. It will include interim results from the Phase 1/2a AROMAPT-SC-1001 study.